{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:27Z","timestamp":1793237667180,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.03.014","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:46:45Z","timestamp":1773215205000},"page":"3838-3853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection"],"prefix":"10.1016","volume":"34","author":[{"given":"Eva","family":"Andres-Mateos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio Navas","family":"Enamorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn R.","family":"Calabro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruti","family":"Rayaprolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Patrick","family":"Havlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess E.","family":"Handy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn E.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Rind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford L.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-3197","authenticated-orcid":false,"given":"Shannon E.","family":"Boye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.014_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng1097-164","article-title":"Positional cloning of the gene associated with X-linked juvenile retinoschisis","volume":"17","author":"Sauer","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.03.014_bib2","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/9.12.1873","article-title":"Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells","volume":"9","author":"Grayson","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.03.014_bib3","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1074\/jbc.M413117200","article-title":"RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer","volume":"280","author":"Wu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.03.014_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.preteyeres.2011.12.002","article-title":"X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms","volume":"31","author":"Molday","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2026.03.014_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archopht.118.8.1098","article-title":"Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene","volume":"118","author":"Eksandh","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.03.014_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2003.12.007","article-title":"X-linked retinoschisis: a clinical and molecular genetic review","volume":"49","author":"Tantri","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.03.014_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ophtha.2021.09.021","article-title":"X-Linked Retinoschisis: Novel Clinical Observations and Genetic Spectrum in 340 Patients","volume":"129","author":"Hahn","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2026.03.014_bib8","first-page":"149","article-title":"The natural history of X-linked retinoschisis","volume":"33","author":"Roesch","year":"1998","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.03.014_bib9","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I\/IIa Trial by Intravitreal Delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.014_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/humc.2015.077","article-title":"Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice","volume":"26","author":"Ye","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.014_bib12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/gt.2014.31","article-title":"Retinoschisin gene therapy in photoreceptors, Muller glia or all retinal cells in the Rs1h-\/- mouse","volume":"21","author":"Byrne","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ymthe.2005.06.002","article-title":"Prolonged recovery of retinal structure\/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis","volume":"12","author":"Min","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/mt.2008.57","article-title":"Effect of late-stage therapy on disease progression in AAV-mediated rescue of photoreceptor cells in the retinoschisin-deficient mouse","volume":"16","author":"Janssen","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ymthe.2020.04.002","article-title":"Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy","volume":"28","author":"Boye","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.014_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(24)01447-8","article-title":"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1\/2, multicentre, open-label, unilateral dose escalation study","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.03.014_bib19","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1167\/iovs.06-1465","article-title":"Coexpression and interaction of wild-type and missense RS1 mutants associated with X-linked retinoschisis: its relevance to gene therapy","volume":"48","author":"Dyka","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.03.014_bib20","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1073\/pnas.092528599","article-title":"Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure","volume":"99","author":"Weber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.03.014_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.6","article-title":"The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo","volume":"3","author":"Kyostio-Moore","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.014_bib22","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","article-title":"Quantitative analysis of the packaging capacity of recombinant adeno-associated virus","volume":"7","author":"Dong","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib23","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.gt.3302979","article-title":"The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors","volume":"14","author":"Higashimoto","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/gt.2009.3","article-title":"Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS","volume":"16","author":"Zanta-Boussif","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib25","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.17-22402","article-title":"Subretinal Injection for Gene Therapy Does Not Cause Clinically Significant Outer Nuclear Layer Thinning in Normal Primate Foveae","volume":"58","author":"Ochakovski","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.03.014_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ajo.2021.10.012","article-title":"Longitudinal Assessment of Ellipsoid Zone Recovery Using En Face Optical Coherence Tomography After Retinal Detachment Repair","volume":"236","author":"Figueiredo","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.03.014_bib27","first-page":"4399","article-title":"18 month analysis of macular structure using optical coherence tomography (OCT) from a phase 1\/2 clinical study of subretinal gene therapy drug AGTC-501 for X-linked retinitis pigmentosa","volume":"63","author":"Yang","year":"2022","journal-title":"ARVO. IOVS"},{"key":"10.1016\/j.ymthe.2026.03.014_bib28","series-title":"AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017","year":"2017"},{"key":"10.1016\/j.ymthe.2026.03.014_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.014_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135112","article-title":"In vivo-directed evolution of adeno-associated virus in the primate retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.03.014_bib31","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.ymthe.2023.10.001","article-title":"Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion","volume":"31","author":"Kellish","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib32","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.ymthe.2021.02.013","article-title":"Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I\/IIa gene therapy trial","volume":"29","author":"Mishra","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.014_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12865-025-00741-4","article-title":"Immune landscape in children with X-linked retinoschisis","volume":"26","author":"Hsu","year":"2025","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ymthe.2026.03.014_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.66.14.27","article-title":"Subretinal Injection Volume Correlates to Persistent Outer Retinal Thinning in the Pig Eye","volume":"66","author":"Seitz","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.03.014_bib35","series-title":"Agreement Advancing X-Linked Retinoschisis Gene Therapy Program","year":"2021"},{"key":"10.1016\/j.ymthe.2026.03.014_bib36","series-title":"Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I\/II\/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-Linked Retinoschisis","year":"2025"},{"key":"10.1016\/j.ymthe.2026.03.014_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:19Z","timestamp":1793236999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626001991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626001991"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.014","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laterally spreading AAV.SPR enables safe and efficient RS1 delivery to the macula after peripheral subretinal injection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}